A blended-style global all-cap equity fund seeking growth.
Is this fund right for you?
- A person who is investing for the longer term, seeking the growth potential of foreign stocks and is comfortable with Medium risk.
- A person who is investing for the longer term, seeking the growth potential of foreign stocks and is comfortable with Medium risk.
- Since the fund invests in stocks its value is affected by stock prices, which can rise and fall in a short period of time.
- Since the fund invests in stocks its value is affected by stock prices, which can rise and fall in a short period of time.
Risk Rating
How is the fund invested?
(as of December 31, 2022)
Asset allocation (%)
|
Name |
Percent |
|
US Equity |
44.0 |
|
International Equity |
42.0 |
|
Canadian Equity |
8.5 |
|
Cash and Equivalents |
5.4 |
|
Income Trust Units |
0.2 |
|
Other |
-0.1 |
Geographic allocation (%)
|
Name |
Percent |
|
United States |
44.0 |
|
Canada |
13.9 |
|
United Kingdom |
4.5 |
|
France |
4.4 |
|
India |
3.6 |
|
Denmark |
3.5 |
|
China |
3.4 |
|
Switzerland |
3.3 |
|
Japan |
2.7 |
|
Other |
16.7 |
Sector allocation (%)
|
Name |
Percent |
|
Healthcare |
19.3 |
|
Financial Services |
13.5 |
|
Technology |
12.7 |
|
Energy |
10.9 |
|
Consumer Goods |
9.6 |
|
Industrial Goods |
9.0 |
|
Consumer Services |
8.9 |
|
Cash and Cash Equivalent |
5.4 |
|
Industrial Services |
4.0 |
|
Other |
6.7 |
Growth of $10,000
(since inception)
Data not available based on date of inception
Fund details
(as of December 31, 2022)
| Top holdings |
% |
| UnitedHealth Group Inc |
3.2 |
| Eli Lilly and Co |
2.5 |
| Canada Government 0.00% 19-Jan-2023 |
2.4 |
| Microsoft Corp |
2.3 |
| Canada Government 0.00% 05-Jan-2023 |
2.3 |
| Novo Nordisk A/S Cl B |
2.2 |
| Taiwan Semiconductor Manufactrg Co Ltd |
2.1 |
| Reliance Industries Ltd |
1.9 |
| Thermo Fisher Scientific Inc |
1.6 |
| Caterpillar Inc |
1.4 |
| Total allocation in top holdings |
21.9 |
| Portfolio characteristics |
|
| Standard deviation |
- |
| Dividend yield |
1.6% |
| Average market cap (million) |
$235,339.3 |
Understanding returns
Annual compound returns (%)
| 1 MO |
3 MO |
YTD |
1 YR |
| {{snapShot.Return1Mth|customNumber:1}} |
{{snapShot.Return3Mth|customNumber:1}} |
{{snapShot.ReturnYTD|customNumber:1}} |
{{snapShot.Return1Yr|customNumber:1}} |
| 3 YR |
5 YR |
10 YR |
INCEPTION |
| {{snapShot.Return3Yr|customNumber:1}} |
{{snapShot.Return5Yr|customNumber:1}} |
{{snapShot.Return10Yr|customNumber:1}} |
{{snapShot.ReturnInception|customNumber:1}} |
Calendar year returns (%)
|
2022 |
2021 |
2020 |
2019 |
| {{snapShot.Return1YrCalendar|customNumber:1}} |
{{snapShot.Return2YrCalendar|customNumber:1}} |
{{snapShot.Return3YrCalendar|customNumber:1}} |
{{snapShot.Return4YrCalendar|customNumber:1}} |
|
2018 |
2017 |
2016 |
2015 |
| {{snapShot.Return5YrCalendar|customNumber:1}} |
{{snapShot.Return6YrCalendar|customNumber:1}} |
{{snapShot.Return7YrCalendar|customNumber:1}} |
{{snapShot.Return8YrCalendar|customNumber:1}} |
Range of returns over five years
| Best return |
Best period end date |
Worst return |
Worst period end date |
|
Data not available based on date of inception
|
| Average return |
% of periods with positive returns |
Number of positive periods |
Number of negative periods |
|
Data not available based on date of inception
|